Literature DB >> 3180072

Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.

L C Oomen1, M A van der Valk, A A Hart, P Demant, P Emmelot.   

Abstract

The influence of the major histocompatibility complex (MHC) of the mouse (H-2) on carcinogen-induced tumorigenesis was investigated. Mice of five H-2 congenic strains on the C57BL/10 background were treated with the direct-acting carcinogen N-ethyl-N-nitrosourea at the age of 15 days, and examined for tumors when moribund. Significant differences between strains in susceptibility to N-ethyl-N-nitrosourea-induced tumors in lung, small intestine, and liver were found. For lung tumors the strains B10.A and 2R were most susceptible, the strains 4R and B10 were relatively resistant. The strain 5R was intermediate. Susceptibility to small intestine tumors was highest in the strain 2R, intermediate in the strain B10.A, the strains 4R, 5R, and B10 were relatively resistant. The location of the tumors in the intestine was also affected by H-2. In the strain 2R most tumors are located in the proximal part, in 4R in the distal part. Tumorigenesis in the liver was highest in the strain 2R, intermediate in the strains B10.A, 4R, and B10, and lowest in the strain 5R. We conclude that susceptibility to carcinogen-induced tumors in the lung, small intestine, and liver in congenic strains on the C57BL/10 background is H-2 haplotype dependent. Susceptibility to tumors in the lung and intestine has a similar strain distribution, but differs from that for liver tumors. Males were more susceptible than females in the strain B10 (lung tumors) and 4R (small intestine and liver tumors). This indicates haplotype- and organ-specific, sex-related influences on tumor development. The possible mechanism(s) of H-2 effects on chemically induced tumorigenesis are discussed. Apart from the well-known immunological functions of the MHC, the involvement of hormonally related effects of the MHC is considered as well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180072

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia.

Authors:  S M Moazzeni; A A Amirzargar; F Shokri
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Authors:  T M Poole; N R Drinkwater
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  Major histocompatibility complex, t-complex, and leukemia.

Authors:  M T Dorak; A K Burnett
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

4.  Genetic control of susceptibility to diethylnitrosamine and dimethylbenzanthracene carcinogenesis in rats.

Authors:  M F Melhem; H W Kunz; T J Gill
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

5.  Human helicase gene SKI2W in the HLA class III region exhibits striking structural similarities to the yeast antiviral gene SKI2 and to the human gene KIAA0052: emergence of a new gene family.

Authors:  A W Dangel; L Shen; A R Mendoza; L C Wu; C Y Yu
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.

Authors:  A R Moser; E M Mattes; W F Dove; M J Lindstrom; J D Haag; M N Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  A major histocompatibility complex-linked locus in the rat critically influences resistance to diethylnitrosamine carcinogenesis.

Authors:  M F Melhem; H W Kunz; T J Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse.

Authors:  G Röpcke; C J Moen; A A Hart; P Demant
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.